KDR Antibody - N-terminal region

Catalog Number: ASB-AVARP20010_P050
Article Name: KDR Antibody - N-terminal region
Biozol Catalog Number: ASB-AVARP20010_P050
Supplier Catalog Number: AVARP20010_P050
Alternative Catalog Number: ASB-AVARP20010_P050-25UL,ASB-AVARP20010_P050-100UL
Manufacturer: Aviva
Host: Rabbit
Category: Proteine/Peptide
Application: IHC, WB
Species Reactivity: Bovine, Canine, Equine, Human, Porcine
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human KDR
Alternative Names: FLK1, CD309, VEGFR, VEGFR2
KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposis sarcoma lesions.
Clonality: Polyclonal
Concentration: 0.5 mg/ml
Molecular Weight: 151kDa
NCBI: 3791
UniProt: P35968
Form: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
KDR in endothelial cells in blood vessels in placenta was detected using HRP/AEC red color stain.recommended for IHC on human tissue.5-10 ug/mL
Researcher: Department of Pathology, Hospital de Carabineros de Chile, Santiago, Chile
Application: IHC
Species+tissue/cell type: Control-Human Placenta, Sample-Human colorectal cancer
Primary antibody dilution: 1:100
Secondary antibody: Biotinylated pig anti-rabbit+streptavidin-HRP
WB Suggested Anti-KDR Antibody Titration: 0.2-1 ug/ml
ELISA Titer: 1:62500
Positive Control: Human Lung
Host: Rabbit
Target Name: KDR
Sample Tissue: Human A549 Whole Cell
Antibody Dilution: 1ug/ml
KDR antibody - N-terminal region (AVARP20010_P050) in Human Lung using Western Blot